Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
The change in free-to-total prostate-specific antigen during progression to androgen-independent state in prostate cancer patients: utilization for intermittent androgen suppression therapy
K Akakura
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Novel biochemical markers for the endocrine management of prostate cancer: serum chromogranin A and interleukin-6
K Akakura
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 1, 1997
[Renal acidification test]
K Akakura, H Ito
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 1, 1997
[Androgen receptor]
J Shimazaki, K Akakura, H Ito
International Journal of Clinical Oncology
|
June 22, 2010
Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer
Y Furuya, K Akakura, H Ito
Journal of Cancer Research and Clinical Oncology
|
January 1, 1996
Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancer
K Akakura, S Akimoto, J Shimazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 1, 1987
[Androgen receptors]
J Shimazaki, T Kodama, K Akakura
Japanese Journal of Clinical Oncology
|
June 1, 1996
Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer
S Akimoto, K Akakura, J Shimazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
October 7, 2000
[Intermittent androgen suppression for prostate cancer]
K Akakura, H Ito, N Sato
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 22, 2001
Assessment of renal function with color Doppler ultrasound in autosomal dominant polycystic kidney disease
A Kondo, K Akakura, H Ito
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
The change in free-to-total prostate-specific antigen during progression to androgen-independent state in prostate cancer patients: utilization for intermittent androgen suppression therapy
K Akakura
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Novel biochemical markers for the endocrine management of prostate cancer: serum chromogranin A and interleukin-6
K Akakura
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 1, 1997
[Renal acidification test]
K Akakura, H Ito
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 1, 1997
[Androgen receptor]
J Shimazaki, K Akakura, H Ito
International Journal of Clinical Oncology
|
June 22, 2010
Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer
Y Furuya, K Akakura, H Ito
Journal of Cancer Research and Clinical Oncology
|
January 1, 1996
Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancer
K Akakura, S Akimoto, J Shimazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 1, 1987
[Androgen receptors]
J Shimazaki, T Kodama, K Akakura
Japanese Journal of Clinical Oncology
|
June 1, 1996
Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer
S Akimoto, K Akakura, J Shimazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
October 7, 2000
[Intermittent androgen suppression for prostate cancer]
K Akakura, H Ito, N Sato
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 22, 2001
Assessment of renal function with color Doppler ultrasound in autosomal dominant polycystic kidney disease
A Kondo, K Akakura, H Ito
Page
of 11